Keywords: speedel, welcomes, positive, spp100, ph, ii/iii, trial

Speedel welcomes positive SPP100 Ph II/III trial data

Article | 18 September 2006

Print This

Swiss biopharmaceutical company Speedel said that data from Phase II/III trials of the oral renin inhibitor SPP100 (aliskiren, Rasilez) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in